Ona Therapeutics Funding: $117M Raised, Series B (2026)
Ona Therapeutics is based in Barcelona, Spain. It has raised $117M in total funding. Latest round: Series B.
Ona Therapeutics funding overview
Ona Therapeutics is based in Barcelona, Spain. Ona Therapeutics has raised $117M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in June 2026. The round record for Ona Therapeutics runs through 2026; nothing later has been disclosed. Investors on record include /Columbus Venture Partners/, /Mrieux Equity Partners/, /COFIDES/, /Korys/, /Alta Life Sciences/, /Asabys Partners/ and 4 others. 10 distinct backers are named across the disclosed rounds.
Ona Therapeutics has raised $117M in total disclosed funding across the rounds on record.
Who has invested in Ona Therapeutics?
/Columbus Venture Partners/, /Mrieux Equity Partners/, /COFIDES/, /Korys/, /Alta Life Sciences/, /Asabys Partners/ are named among the investors backing Ona Therapeutics.
What was the latest Ona Therapeutics funding round?
The most recent disclosed round is a Series B, announced in June 2026.
Where is Ona Therapeutics based?
Ona Therapeutics is based in Barcelona, Spain.
When did Ona Therapeutics last raise?
The last disclosed Ona Therapeutics round closed in June 2026 at Series B.
Ona Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Barcelona below to benchmark round size and investor mix.
